IDD Biotech – differentiated therapeutic MAbs

IDD biotech aims to improve the life of patients by developing differentiated therapeutic MAbs for the pharmaceutical market with a pipeline of internally discovered product candidates and strategic collaborations with research institutes and pharmaceutical companies.

IDD Biotech – differentiated therapeutic MAbs

IDD Biotech

Continue reading

Innate Pharma – therapeutic antibodies

Innate Pharma is a biopharma company developing therapeutic antibodies for the treatment of cancer and inflammatory diseases.

Innate Pharma – therapeutic antibodies

innate pharma
Continue reading

Medigene – personalized immunotherapies

Medigene is a biotech company focusing on the development of personalized T-cell immunotherapies. Medigene develops highly innovative treatment platforms concentrating on haematological malignancies, cancer and autoimmune diseases.

Medigene – personalized immunotherapies

medigene Continue reading

Zenith Epigenetics – bromodomain inhibitors

Zenith Epigenetics is a biotech company developing bromodomain (BET) inhibitors for the treatment of cancer and autoimmune disorders. Zenith Epigenetics aims to become a leading epigenetic company translating bromodomain biology into impactful therapies.

Zenith Epigenetics – bromodomain inhibitors

Zenith Epigenetics

Continue reading

Biocon – delivering affordable innovation

Biocon, India’s largest biotech company, is focused on delivering affordable innovation by leveraging India’s cost advantage to reduce therapy costs of chronic diseases like diabetes, cancer and autoimmune diseases.

Biocon – delivering affordable innovation

Biocon

Continue reading